Clinical Trials Logo

Clinical Trial Summary

in this study the investigators will measure the colchicine trough levels in 80 FMF patients taking stable doses of colchicine


Clinical Trial Description

80 FMF patients will enroll: 20 taking 1 mg colchicine a day 20 taking 1.5 mg colchicine a day 20 taking 2 mg colchicine a day 20 taking 2.5 mg colchicine a day one blood sample for trough colchicine levels will be taken. response to treatment, colchicine side effects and anthropometric data will be collected. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03210610
Study type Observational
Source Sheba Medical Center
Contact merav lidar, prof
Phone +972-3-5304413
Email merav.lidar@sheba.health.gov.il
Status Recruiting
Phase
Start date October 19, 2017
Completion date July 15, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT05190991 - Safety and Efficacy of RPH-104 Used to Prevent Recurrent Fever Attacks in Adult Patients With Colchicine Resistant or Colchicine Intolerant Familial Mediterranean Fever Phase 2
Not yet recruiting NCT06336733 - Randomized Controlled Trial in Patients on Long-term Colchicine With Colchicine-resistant Familial Mediterranean Fever (FMF) to Evaluate the Efficacy of On-demand Anakinra Treatment for Painful Attacks in Patients Who Refuse Continuous Daily Therapy Phase 3
Not yet recruiting NCT05292768 - Are Mast Cells Involved in Autoinflammatory Diseases
Enrolling by invitation NCT04402255 - Pilates Based Exercises in Patients With Behçet and Familial Mediterranean Fever. N/A
Completed NCT02466217 - Phenomics in Autoimmune and Inflammatory Diseases
Recruiting NCT05980780 - The Effect of Video Game on Children With Familial Mediterranean Fever N/A
Completed NCT05398536 - Kinesiophobia in Familial Mediterranean Fever
Not yet recruiting NCT06047938 - FMF and Atheroscelerosis
Recruiting NCT05092776 - Efficacy and Safety of RPH-104 for Resolution and Prevention of Recurring Attacks in Adult Subjects With Familial Mediterranean Fever With Resistance to or Intolerance of Colchicine Phase 2
Enrolling by invitation NCT04403438 - Familial Mediterranean Fever and Behçet: Analysis Before and After Covid19 Pandemic